ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 744063 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 744063; 2) Community: the network communities that were significantly associated with the response to NSC 744063; 3) Molecule: the relationships between components within communities and NSC 744063; 4) MDR: the compounds that were significantly associated with the NSC 744063.

NSC Compound Enrichment Correlation
NSC 668264 Null 0.0385613993886001 0.48275088
NSC 670784 Null 0.0385613993886001 0.26050292
NSC 671765 3-[2-pyrrolidino] ethoxy-17-butyl-17-aza-1,3,5(10)-estratriene-16,17.alpha.-dione 0.0385613993886001 0.26811889
NSC 672058 Null 0.0385613993886001 0.15188107
NSC 678040 Methanone, (tricyclo[3.3.1.1(3,7)]decan-1-yl) [3-(3-nitrophenyl)-2-oxiranyl]- 0.0385613993886001 0.1449379
NSC 681641 Camptothecin Derivative 0.0385613993886001 0.20869502
NSC 683694 Null 0.0385613993886001 0.2212908
NSC 685981 1,4-Butanediamine, N,N'-bis[(2-naphthalenyl)methyl- N,N'-bis[3-[(trifluoroacetyl)amino]propyl]- 0.0385613993886001 0.31611544
NSC 687578 Null 0.0385613993886001 0.29990625
NSC 688074 16,24-Cyclo-13,14-secoergost-2-ene-18,26-dioic acid, 5-chloro-14,17:14,27-diepoxy-6,13,20,22-tetrahydroxy-1,15-dioxo-, .gamma.-lactone .delta.-lactone 0.0385613993886001 0.46999929
Total:152  Current:113    [First] [Prev] [Next] [Last]